Comparison of endocrine therapy and chemotherapy as different systemic treatment modes for metastatic luminal HER2-negative breast cancer patients —A retrospective study

PurposeThe purpose of this study was to evaluate endocrine therapy and chemotherapy for first-line, maintenance, and second-line treatment of hormone receptor-positive HER-2-negative metastatic breast cancer (HR+HER-2-MBC) and the relationship between different treatment options and survival.Patient...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Qiuyue Liu, Juan Qiu, Qianrun Lu, Yujin Ma, Shu Fang, Bing Bu, Lihua Song
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2022-07-01
Цуврал:	Frontiers in Oncology
Нөхцлүүд:	metastatic breast cancer chemotherapy endocrine therapy systemic treatment modes prognosis
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fonc.2022.873570/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!